|
|
市村 恵一 |
自治医科大学名誉教授 |
| 耳鼻咽喉科 |
（研究論文）
Mechanism of nasal obstruction in patients with allergic rhinitis・ Ichimura K ・Clin Exper Allergy Rev. 10:20-27,2010.
|
（研究論文）
Protection of plasminogen activatorinhibitor-1-deficient mice from nasal allergy. Sejima T, Madoiwa S, Mimuro J, Sugo T, Okada S, Ueshima Shi, Matsuo S, Ishida T, Ichimura K, Sakata Y. Immunology 174:8135-8143, 2005.
|
（ガイドライン）
Japanese guidelines for allergic rhinitis 2017. Okubo K, Kurono Y, Ichimura K, Enomoto T, Okamoto Y, Kawauchi H, Suzaki H, Fujieda S, Masuyama K. Allergol Int. 2017 Apr;66(2):205-219,2017.
|
|
| |
|
興梠 博次 |
社会保険大牟田天領病院・病院長 |
| 呼吸器内科学 |
| CD8 and CD103 are highly expressed in asthmatic bronchial intraepithelial lymphocytes, I Hirosako S, Goto E, Tsumori K, Fujii K, Hirata N, Ando M, Kohrogi H. Int Arch Allergy Immunol 2010, 153:157-165.
|
| T cells of atopic asthmatics preferentially infiltrate into human bronchial xenografts in SCID mice, Tsumori K, Kohrogi H, Goto E, Hirata N, Hirosako S, Fujii K, Ando M, Kawano O, Mizuta H: J Immunol 2003, 170:5712-5718.
|
| Allergen exposure induces the expression of endothelial adhesion molecules in passively sensitized human bronchus: time course and the role of cytokines, Hirata N, Kohrogi H, Iwagoe H, Goto E, Hamamoto J, Fujii K, Yamaguchi T, Kawano O, Ando M. Am J Respir Cell Mol Biol 1998, 18:12-20.
|
|
| |
|
桑名 正隆 |
日本医科大学大学院医学研究科 大学院教授 |
| アレルギー・膠原病 |
＜研究論文＞
Distler O, Highland KB, Gahlemann M, Azuma A, Fischer A, Mayes MD, Raghu G, Sauter W, Girard M, Alves M, Clerisme-Beaty E, Stowasser S, Tetzlaff K, Kuwana M, Maher TM. Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 2019; 380(26): 2518-2528.
|
＜研究論文＞
Kuwana M, Blair C, Takahashi T, Langley J, Coghlan JG. Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension in the modified intention-to-treat population of the AMBITION study: a post hoc analysis. Ann Rheum Dis 2020; 79(5): 626-634
|
＜研究論文＞
Gono T, Masui K, Nishina N, Kawaguchi K, Kawakami A, Ikeda K, Kirino Y, Sugiyama Y, Tanino Y, Nunokawa T, Kaneko Y, Sato S, Asakawa K, Ukichi T, Kaieda S, Naniwa T, Okano Y, and Kuwana M. Risk prediction modeling based on a combination of initial serum biomarkers in myositis-associated interstitial lung disease. Arthritis Rheumatol. doi: 10.1002/art.41566. [Epub ahead of print]
|
|
| |
|
竹内 勤 |
慶應義塾大学医学部リウマチ・膠原病内科教授
|
| リウマチ・膠原病学、臨床免疫学 |
（業績・実績その１）
Choy E, de Benedetti F, Takeuchi T, Hashizume M, John MR, and Kishimoto T. Translating IL-6 biology into effective treatments. Nature Rev Rheum (IF=16.625), 16:335-45, 2020.
|
（業績・実績その２）
Hasegawa T, Kikuta J, Sudo T, Matsuura Y, Matsui T, Simmons S, Ebina K, Hirao M, Okuzaki D, Yoshida Y, Hirao A, Kalinichenko V, Rachaudohuri P, Yamaoka K, Takeuchi T, and Ishii M. Identification of a novel arthritis-associated osteoclast precursor macrophage regulated by FoxM1. Nature Immunol (IF=20.479),20:1631-43, 2019.
|
（業績・実績その３）
Takeuchi T, Tanaka Y, Soen S, Yamanaka H, Yoneda T, Tanaka S, Nitta T, Okubo N, Genant HK, and van der Heijde. Effect of anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying anti-rhuematic drugs (DESIRABLE study): a randomized, double-blind, placebo-controlled phase 3 trial. Ann Rheum Dis (IF=16.102), 78:899-907, 2019.
|
|
